Dermata Therapeutics Enrolls First Participant in Acne Treatment Trial
Dermata Therapeutics said the first participant has enrolled in a clinical trial of its once-weekly Tome Clearing Treatment for acne.
Related stories
FedEx Freight Forecast to Exceed Quarterly Earnings Expectations
The Korean headline says FedEx Freight expects quarterly results to exceed market expectations, citing improved shipment volumes and freight rates. The supplied body is truncated a
M impact | EQUITY | Oct 30, 2026, 08:15 AM UTC
Nikkei Falls More Than 2% as Japanese Bonds Hold Firm
Japanese government bond prices held firm while the yen gave back gains. The Bank of Japan signaled vigilance over inflation risks, while unexpectedly accelerating ETF sales.
M impact | EQUITY | Oct 30, 2026, 08:13 AM UTC
Siemens Energy shares fall 5.2%
M impact | EQUITY | Oct 30, 2026, 08:13 AM UTC
Riot Platforms, Hut 8 and MARA Shares Fall
Riot Platforms fell 5.3%, Hut 8 fell 5.5% and MARA Holdings fell 4.7%.
M impact | EQUITY | Oct 30, 2026, 08:13 AM UTC
Hang Seng Tech Index Falls 11.7% This Month, Biggest Monthly Drop Since January 2024
Hong Kong's Hang Seng Tech Index closed down 11.7% for the month, its largest monthly decline since January 2024.
M impact | EQUITY | Oct 30, 2026, 08:12 AM UTC
Asian markets close mixed: Nikkei 225 -2.12%, Hang Seng +0.92%, Shanghai Composite -2.24%, KOSPI -3.48%, ASX 200 +0.69%
Asian cash markets finished mixed: the Nikkei 225 closed down 2.12 percent, the Hang Seng closed up 0.92 percent, the Shanghai Composite closed down 2.24 percent, the KOSPI closed
M impact | EQUITY | Oct 30, 2026, 08:11 AM UTC